Characterization of Epileptic Motor Patterns by Tridimensional Analysis of Movement 2

NCT ID: NCT01025401

Last Updated: 2010-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

This is done to obtain a 3-D motor signature of seizures, for a given patient, and allows their detection with an ambulatory monitoring system.

The benefit for patients is to improve the diagnosis of their diseases by better characterizing their seizures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

The project is planned in three phases:

* Installation of 3-D accelerometric and magnetic sensors acquisition systems on the hospital (extension of a preceding study CAPAMETRIM).
* Collection of data on epileptic patients. Sensors will be positioned on the right and left hands and on the head. A 3-D analysis of movements will be done according to the collection by tagging data with visual analysis made on video.
* Development of a motor pattern classification system used for seizure detection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epileptic Patients With Motor Manifestations During Seizures

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

epilepsy seizures movement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motor manifestations during seizures

Group Type NO_INTERVENTION

3-D accelerometric and magnetic sensors

Intervention Type DEVICE

sensors are positioned on the right wrist, the left wrist and on the head.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3-D accelerometric and magnetic sensors

sensors are positioned on the right wrist, the left wrist and on the head.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult or children (\>= 6 years)
* Written inform consented from the patient or its legal representative
* Presurgical investigation of pharmaco-resistant partial epilepsy
* Motor manifestations during seizures

Exclusion Criteria

* Proved generalized epilepsy
* No motor manifestations during seizures
* Pregnant women
* Subjects deprived of freedom by an administrative or judicial decision
Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Hospital, Grenoble

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Kahane, MD PHD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Grenoble

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Grenoble University Hospital Epilepsy Monitoring Unit

Grenoble, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-A00196-51

Identifier Type: REGISTRY

Identifier Source: secondary_id

0905

Identifier Type: -

Identifier Source: org_study_id